Genmab — Juli 2018
-
Det ser sådan ud.
-
Klumpen er pænt reduceret nu.
-
Hvad er klumpen reduceret til?
-
Kl. 14.48 var den reduceret til omkring 5.000. Derefter blev der internt i A/B-gruppen solgt ned gennem hylderne. 1.140 er ikke sådan lige til at bryde igennem.
-
Vi har flere gange intraday været oppe over intraday, men det holder ikke i mål.
-
Ok, men trods alt en fin dag når man tager et negativt marked i betragtning.
-
Jeps.
-
-
God morgen
-
God morgen.
-
on the approval, Dr Mateos says “Selecting the right treatment regimen for newly diagnosed patients is critical to their long-term survival, especially those who are transplant ineligible, so daratumumab could offer an important new standard of care in this indication.” https://www.epmmagazine.com/news/chmp-recommends-daratumumab-as-a-frontline-treatment/
-
Tak for link E L.
-
Vi var tæt på 1.150 i går. Her lå der mange til salg og vi fik efterfølgende et udsalg ned gennem hylderne fra A/B. Dette forsætter i dag, hvor 1.120 bliver testet.
-
1.120 er testet flere gange i den seneste tid. Ser ud til at holde.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind